Literature DB >> 6417027

Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.

C D Buckner, R A Clift, E D Thomas, J Hersman, J E Sanders, P S Stewart, J C Wade, M Murphy, G Counts, J D Meyers.   

Abstract

One hundred eighty-two patients with acute leukemia underwent allogeneic marrow transplantation and received one of two forms of infection prophylaxis: isolation and decontamination procedures in laminar air flow rooms (90 patients) or prophylactic granulocyte transfusion from a single family member (92 patients). Infection acquisition and survival were analyzed from the time of admission to 100 days posttransplant. There were 20 major local infections in the laminar air flow group and 16 in the prophylactic granulocyte group. Of the patients in the laminar air flow group, 24 (27%) had 27 episodes of bacteremia, while 23 (25%) of the prophylactic granulocyte group had 25 episodes of bacteremia. There were no significant differences in infection acquisition between the two groups during the period of granulocytopenia or after engraftment. The mortality during the first 100 days was 28% for the laminar air flow group and 35% for the prophylactic granulocyte group. Thirteen patients (14%) in the laminar air flow group and five (5%) in the prophylactic granulocyte group died with bacterial or fungal infections. There were no statistically significant differences between the two groups in overall incidence of or mortality from interstitial pneumonitis which was the predominant cause of death. However, the subset of patients who were seronegative for cytomegalovirus antibody at the time of transplant and received granulocytes from seropositive donors had a significantly higher incidence of and mortality from cytomegalovirus interstitial pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417027     DOI: 10.1007/BF01641254

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  THE TREATMENT OF X-IRRADIATED GERMFREE CFW AND C3H MICE WITH ISOLOGOUS AND HOMOLOGOUS BONE MARROW.

Authors:  M S CONNELL; R WILSON
Journal:  Life Sci (1962)       Date:  1965-03

Review 2.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

3.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Authors:  E D Thomas; C D Buckner; R A Clift; A Fefer; F L Johnson; P E Neiman; G E Sale; J E Sanders; J W Singer; H Shulman; R Storb; P L Weiden
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

4.  Experience with double lumen right atrial catheters.

Authors:  J E Sanders; R O Hickman; S Aker; J Hersman; C D Buckner; E D Thomas
Journal:  JPEN J Parenter Enteral Nutr       Date:  1982 Mar-Apr       Impact factor: 4.016

5.  Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation.

Authors:  R A Clift; C D Buckner; E D Thomas; J E Sanders; P S Stewart; R McGuffin; J Hersman; K M Sullivan; G E Sale; R Storb
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

6.  Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation.

Authors:  E D Thomas; R A Clift; J Hersman; J E Sanders; P Stewart; C D Buckner; A Fefer; R McGuffin; J W Smith; R Storb
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-05       Impact factor: 7.038

7.  Protective environment for marrow transplant recipients: a prospective study.

Authors:  C D Buckner; R A Clift; J E Sanders; J D Meyers; G W Counts; V T Farewell; E D Thomas
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

8.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

9.  The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.

Authors:  J Hersman; J D Meyers; E D Thomas; C D Buckner; R Clift
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

10.  Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission.

Authors:  C D Buckner; R A Clift; E D Thomas; J E Sanders; R Hackman; P S Stewart; R Storb; K M Sullivan
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

View more
  9 in total

1.  Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients.

Authors:  F B Petersen; C D Buckner; R A Clift; S Lee; N Nelson; G W Counts; J D Meyers; J E Sanders; P S Stewart; W I Bensinger
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

Review 2.  Granulocyte transfusions in the management of invasive fungal infections.

Authors:  Kamille A West; Juan Gea-Banacloche; David Stroncek; Sameer S Kadri
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

3.  The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study.

Authors:  F Petersen; M Thornquist; C Buckner; G Counts; N Nelson; J Meyers; R Clift; E Thomas
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

4.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

Review 5.  Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future.

Authors:  L S Young
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

6.  Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.

Authors:  T Schmeiser; E Kurrle; R Arnold; D Krieger; W Heit; H Heimpel
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 7.  Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Patricia Blanco; Sally Hopewell; Marialena Trivella; Edwin Massey
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

8.  [Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir].

Authors:  P Ostendorf; G Ehninger; R Dopfer; H Schmidt; M Haen; H Link; K Schüch; C A Müller; P Wernet; T Klingebiel
Journal:  Klin Wochenschr       Date:  1986-05-15

9.  Lung diseases after bone marrow transplantation. Results of a clinical, radiological, histological, immunological and lung function study.

Authors:  H Link; U Reinhard; E Walter; P Wernet; E M Schneider; H Fischbach; M Blaurock; K Wilms; D Niethammer; P Ostendorf
Journal:  Klin Wochenschr       Date:  1986-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.